Abstract
The family of NADPH oxidase (Nox) proteins plays an integral role in the homeostatic functions of the cell, including gene expression, cell migration, proliferation, senescence and inflammation. There are currently 4 isoforms (Nox1, 2, 4 and 5) that are expressed across all cell types of the vascular system and play an important role in many physiological processes such as endothelial function, vascular tone and angiogenesis. The balance between Nox derived reactive oxygen species production and their elimination by dismutase enzymes is a critical finely tuned process. It is when this balance is shifted in disease states, either leading to an over- or under-production of reactive oxygen species that vascular injury develops. To date, Nox isoforms have been linked to the development of many vascular diseases including hypertension, atherosclerosis and stroke. The contribution of each isoform to the pathophysiology of vascular disease appears to be a matter of debate with most studies suggesting that Nox1 oxidase and Nox2 oxidase play deleterious roles, whereas Nox4 oxidase potentially plays a protective role in the vasculature. This review will discuss the current knowledge on the role of Nox derived oxidative stress in the pathophysiology of various vascular diseases including hypertension and atherosclerosis.
Keywords: Nox, vascular disease, hypertension, atherosclerosis.
Current Pharmaceutical Design
Title:The role of NADPH Oxidase in Vascular Disease – Hypertension, Atherosclerosis & Stroke
Volume: 21 Issue: 41
Author(s): Stephen P Gray and Karin AM Jandeleit-Dahm
Affiliation:
Keywords: Nox, vascular disease, hypertension, atherosclerosis.
Abstract: The family of NADPH oxidase (Nox) proteins plays an integral role in the homeostatic functions of the cell, including gene expression, cell migration, proliferation, senescence and inflammation. There are currently 4 isoforms (Nox1, 2, 4 and 5) that are expressed across all cell types of the vascular system and play an important role in many physiological processes such as endothelial function, vascular tone and angiogenesis. The balance between Nox derived reactive oxygen species production and their elimination by dismutase enzymes is a critical finely tuned process. It is when this balance is shifted in disease states, either leading to an over- or under-production of reactive oxygen species that vascular injury develops. To date, Nox isoforms have been linked to the development of many vascular diseases including hypertension, atherosclerosis and stroke. The contribution of each isoform to the pathophysiology of vascular disease appears to be a matter of debate with most studies suggesting that Nox1 oxidase and Nox2 oxidase play deleterious roles, whereas Nox4 oxidase potentially plays a protective role in the vasculature. This review will discuss the current knowledge on the role of Nox derived oxidative stress in the pathophysiology of various vascular diseases including hypertension and atherosclerosis.
Export Options
About this article
Cite this article as:
Gray P Stephen and Jandeleit-Dahm AM Karin, The role of NADPH Oxidase in Vascular Disease – Hypertension, Atherosclerosis & Stroke, Current Pharmaceutical Design 2015; 21 (41) . https://dx.doi.org/10.2174/1381612821666151029112302
DOI https://dx.doi.org/10.2174/1381612821666151029112302 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Cardiovascular Modulating Effects of Magnolol and Honokiol, Two Polyphenolic Compounds from Traditional Chinese Medicine-Magnolia Officinalis
Current Drug Targets Induction of Propranolol Metabolism by Ginkgo biloba Extract EGb 761 in Rats
Current Drug Metabolism Anti-HER2 Therapy in Elderly Breast Cancer Patients
Reviews on Recent Clinical Trials Pleiotropic Effects of Fenofibrate
Current Pharmaceutical Design Gene Therapy Approaches for Cardiovascular Diseases
Current Gene Therapy Antiphospholipid Syndrome: Characteristics and Obstetrical Management
Current Drug Targets Relationship of High-Sensitivity C-Reactive Protein Concentrations and Systolic Heart Failure
Current Vascular Pharmacology The Co-Existence of NASH and Chronic Kidney Disease Boosts Cardiovascular Risk: Are there any Common Therapeutic Options?
Current Vascular Pharmacology Histamine H3 Antagonists as Wake-Promoting and Pro-Cognitive Agents
Current Topics in Medicinal Chemistry Modern Alchemy with Metal Complexes Inside Cyclodextrins, The Molecular Cauldrons
Current Organic Chemistry Monoclonal Antibodies in the Treatment of Leukemia
Current Molecular Medicine Inflammatory Syndrome in Chronic Kidney Disease: Pathogenesis and Influence on Outcomes
Inflammation & Allergy - Drug Targets (Discontinued) Potential Effect of Anti-Inflammatory Treatment on Reducing the Cardiovascular Risk in Rheumatoid Arthritis
Current Vascular Pharmacology Differential Impacts of Antihypertensive Drugs on Central Blood Pressure and Their Clinical Significance
Current Hypertension Reviews PDE5 Inhibitors in the Treatment of LUTS
Current Pharmaceutical Design Modulation of Potassium Channels as a Therapeutic Approach
Current Pharmaceutical Design G Protein-Coupled Receptors and their Signaling Pathways: Classical Therapeutical Targets Susceptible to Novel Therapeutic Concepts
Current Pharmaceutical Design Crystal Structures of Phosphodiesterases and Implications on Substrate Specificity and Inhibitor Selectivity
Current Topics in Medicinal Chemistry Long-Term Use of Short- and Long-Acting Nitrates in Stable Angina Pectoris
Current Clinical Pharmacology Lock Stock and Barrel of Wound Healing
Current Pharmaceutical Design